Retrograde Reperfusion Versus Antegrade Liver Transplant Reperfusion
NCT ID: NCT03846089
Last Updated: 2022-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2002-01-01
2020-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Remote Ischemic Preconditioning in Patients Undergoing Major Liver Surgery
NCT00796588
Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery
NCT05658120
Predictive Factors for Massive Transfusion During Liver Transplantation
NCT05763446
Hypotension Prediction Index in Living Donor Liver Transplantation
NCT05010941
Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss
NCT07111221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrograde reperfusion
After completion of the inferior vena cava anastomosis, the clamps were removed to allow retrograde reperfusion of the graft.
Graft reperfusion
antegrade (forward) or retrograde (backward) blood reperfusion of the liver graft
Antegrade reperfusion
After completion of the inferior vena cava anastomosis, the portal vein anastomosis is completed and then the clamps were removed to allow antegrade reperfusion of the graft.
Graft reperfusion
antegrade (forward) or retrograde (backward) blood reperfusion of the liver graft
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Graft reperfusion
antegrade (forward) or retrograde (backward) blood reperfusion of the liver graft
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* multiorgan transplantation
* ABO incompatible transplantation
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London Health Sciences Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vivian McAlister
Professor of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vivian McAlister
Role: PRINCIPAL_INVESTIGATOR
London Health Sciences Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
106793
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.